Background Uncertainty exists regarding the prevalence and clinical features associated
with the practice of polypharmacy in bipolar disorder (BD), warranting a systematic review …

Objective: Extensive combination pharmacotherapy regimens for bipolar disorder have
gained increasing use in routine practice in ways that outpace data from evidence-based …

Abstract Background Coronavirus disease 2019 (COVID-19) has been found to have a
greater impact on individuals with pre-existing psychiatric disorders. However, the …

Objectives The aim was to describe the pre‐diagnostic and post‐diagnostic
psychopharmacological treatment of bipolar disorder over the past two decades. Methods …

Objectives To investigate the associations between psychotropic medication dosage and
mortality in patients with bipolar disorder. Methods A nationwide cohort of individuals …

Abstract Background and Objectives In Japan, polypharmacy reduction policy, which
reduces the reimbursement of medical cost, was introduced to address unnecessary …

Objective This study aims to clarify the relevant factors influencing practitioners' methods of
prescribing medications for bipolar disorder, in a nation‐wide survey in Japan. Methods The …

Objective: The aim of this study was to observe potential drug–drug interactions in the
medication of Mexican schizophrenic patients. Methods: We performed a retrospective and …

Background Bipolar disorder (BD) is predominantly treated with psychotropic drugs, but BD
is a complex medical condition and the contribution of psychotropic drugs is not clear. The …

Background Because use and dosing of mood stabilizers (MSs) to treat bipolar disorder
(BD) patients in Asia are not well documented, we examined prevalence and clinical …